Growth Metrics

Sarepta Therapeutics (SRPT) Non-cash Items (2016 - 2025)

Sarepta Therapeutics has reported Non-cash Items over the past 16 years, most recently at $399000.0 for Q4 2025.

  • For Q4 2025, Non-cash Items fell 93.63% year-over-year to $399000.0; the TTM value through Dec 2025 reached $399000.0, down 93.63%, while the annual FY2025 figure was $399000.0, 93.63% down from the prior year.
  • Non-cash Items for Q4 2025 was $399000.0 at Sarepta Therapeutics, down from $6.3 million in the prior quarter.
  • Over five years, Non-cash Items peaked at $288.1 million in Q4 2023 and troughed at $399000.0 in Q4 2025.
  • A 5-year average of $109.6 million and a median of $6.3 million in 2024 define the central range for Non-cash Items.
  • Biggest five-year swings in Non-cash Items: tumbled 98.11% in 2022 and later soared 6039.89% in 2023.
  • Year by year, Non-cash Items stood at $248.5 million in 2021, then tumbled by 98.11% to $4.7 million in 2022, then soared by 6039.89% to $288.1 million in 2023, then crashed by 97.82% to $6.3 million in 2024, then crashed by 93.63% to $399000.0 in 2025.
  • Business Quant data shows Non-cash Items for SRPT at $399000.0 in Q4 2025, $6.3 million in Q4 2024, and $288.1 million in Q4 2023.